Part I: A retrospective analysis of 73 liver transplant patients with liver cancer beyond the Milan standard who received TACE "bridging" therapy in our hospital from January 2013 to January 2019, with a follow-up period of 3 years.
Part I: retrospective analysis of 73 patients with super Milan standard liver cancer who received TACE "bridging" treatment in our hospital from January 2013 to January 2019. The follow-up period was 3 years.
Part I: Retrospective analysis of 73 liver transplantation patients with liver cancer beyond Milan standard who received TACE "bridging" treatment in our hospital from January 2013 to January 2019, with a follow-up period of 3 years.